The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

May. 02, 2017
Applicant:

Massachusetts Institute of Technology, Cambridge, MA (US);

Inventors:

Paiman Peter Ghoroghchian, Boston, MA (US);

Ruogu Qi, Houston, TX (US);

Angela M. Belcher, Lexington, MA (US);

Xiangnan Dang, Sharon, MA (US);

Zhimin Tao, Lexington, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 48/00 (2006.01); A61K 47/60 (2017.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); A61K 31/555 (2006.01); A61K 33/24 (2019.01); C08G 81/00 (2006.01); C12N 15/11 (2006.01); A61K 9/107 (2006.01); A61K 31/282 (2006.01); A61K 47/34 (2017.01); C07K 2/00 (2006.01); C08G 69/10 (2006.01); C12N 15/90 (2006.01); A61K 39/00 (2006.01); A61K 47/10 (2017.01); C12N 15/09 (2006.01); G01N 21/47 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0041 (2013.01); A61K 9/107 (2013.01); A61K 31/282 (2013.01); A61K 31/555 (2013.01); A61K 33/24 (2013.01); A61K 39/0011 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01); A61K 47/60 (2017.08); A61K 47/646 (2017.08); A61K 47/6907 (2017.08); A61K 47/6935 (2017.08); A61K 48/005 (2013.01); C07K 2/00 (2013.01); C08G 69/10 (2013.01); C08G 81/00 (2013.01); C12N 15/11 (2013.01); C12N 15/90 (2013.01); A61K 2039/585 (2013.01); C12N 15/09 (2013.01); C12N 2310/20 (2017.05); G01N 21/47 (2013.01);
Abstract

Disclosed are methods of treating cancer of the intraperitoneal cavity using compositions comprising nanoparticles without targeting agents. In addition, nanoparticles are described that comprise a highly toxic anticancer agent (e.g., an anticancer agent having an ICless than 1 nM) covalently bound via a linker to a triblock copolymer. Other nanoparticles that comprise Pt(IV) and an anticancer agent are also described. Also disclosed are nanoparticles comprising imaging agents non-covalently associated with a polymer, and methods of imaging cancer of the intraperitoneal cavity using compositions comprising nanoparticles without targeting agents.


Find Patent Forward Citations

Loading…